Startseite Medizin SHOX gene deletion screening by FISH in children with short stature and Madelung deformity and their characteristics
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

SHOX gene deletion screening by FISH in children with short stature and Madelung deformity and their characteristics

  • Erdal Kurnaz EMAIL logo , Şenay Savaş-Erdeve , Semra Çetinkaya und Zehra Aycan
Veröffentlicht/Copyright: 17. Oktober 2018

Abstract

Background

The short stature homeobox-containing (SHOX) gene strongly affects height. Therefore, a better understanding of SHOX haploinsufficiency could be advantageous to early diagnosis and treatment. We investigated the rate of SHOX haploinsufficiency in patients of short stature and documented their anthropometric measurements.

Methods

Between 2010 and 2017, we evaluated 86 patients (70 females, 16 males; age 4.3–18 years) with clinical diagnoses of short stature and Madelung deformity (MD). Clinical abnormalities are presented for patients with MD with and without SHOX haploinsufficiency as determined by fluorescence in situ hybridisation (FISH).

Results

According to our inclusion criteria, 78 of 86 patients (70 females, 16 males) had short stature (height <−2.5 standard deviation [SD]) and a family history suggestive of short stature. Eight patients had short stature, a family history suggestive of short stature and MD. MD was obvious in eight children in radiographic examinations. Although five of these had no deletion of SHOX, three had deletion of this gene. The deletion detection rate was 37.5% in the individuals with short stature and MD, i.e. Leri-Weill dyschondrosteosis syndrome (LWS), whilst no deletions were detected in the individuals with only short stature. One individual responded well to growth hormone (GH) treatment for the first 2 years but then developed an intolerance with persistently elevated insulin-like growth factor-1 (IGF-1) levels.

Conclusions

As we likely missed cases due to our methodology, the routine analysis for SHOX screening should be firstly multiplex ligation-dependent probe amplification (MLPA). The incidence of MD may have been higher in the cohort if X-rays were performed in all individuals. GH treatment was not well tolerated in one case due to persistently elevated IGF-1 levels, and long-term evaluations of patients with SHOX deficiency are required.


Corresponding author: Erdal Kurnaz, MD, Dr. Sami Ulus Obstetrics and Gynecology, Children Health and Disease Training and Research Hospital, Pediatric Endocrinology, Babür Street, No: 36–38 (06080) Altındağ, Ankara, Turkey, Phone: +90 (312) 305 65 11, Fax: +90 (312) 317 03 53

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organisation(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, et al. 2007 ISS Consensus Workshop participants. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 2008;93:4210–7.10.1210/jc.2008-0509Suche in Google Scholar PubMed

2. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010;467:832–8.10.1038/nature09410Suche in Google Scholar PubMed PubMed Central

3. Rao E, Weiss B, Fukami M, Rump A, Niesler B, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997;16:54–63.10.1038/ng0597-54Suche in Google Scholar PubMed

4. Rappold GA, Fukami M, Niesler B, Schiller S, Zumkeller W, et al. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab 2002;87:1402–6.10.1210/jcem.87.3.8328Suche in Google Scholar PubMed

5. Stuppia L, Calabrese G, Gatta V, Pintor S, Morizio E, et al. SHOX mutations detected by FISH and direct sequencing in patients with short stature. J Med Genet 2003;40:E11.10.1136/jmg.40.2.e11Suche in Google Scholar PubMed PubMed Central

6. Rappold G, Blum WF, Shavrikova EP, Crowe BJ, Roeth R, et al. Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet 2007;44:306–13.10.1136/jmg.2006.046581Suche in Google Scholar PubMed PubMed Central

7. Huber C, Rosilio M, Munnich A, Cormier-Daire V, French SHOX GeNeSIS Module. High incidence of SHOX anomalies in individuals with short stature. J Med Genet 2006;43:735–9.10.1136/jmg.2006.040998Suche in Google Scholar PubMed PubMed Central

8. Rosilio M, Huber-Lequesne C, Sapin H, Carel JC, Blum WF, et al. Genotypes and phenotypes of children with SHOX deficiency in France. J Clin Endocrinol Metab 2012;97:E1257–65.10.1210/jc.2011-3460Suche in Google Scholar PubMed

9. Binder G, Ranke MB, Martin DD. Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature. J Clin Endocrinol Metab 2003;88:4891–6.10.1210/jc.2003-030136Suche in Google Scholar PubMed

10. Morizio E, Stuppia L, Gatta V, Fantasia D, Guanciali Franchi P, et al. Deletion of the SHOX gene in patients with short stature of unknown cause. Am J Med Genet A 2003;119A:293–6.10.1002/ajmg.a.20198Suche in Google Scholar PubMed

11. Jorge AA, Souza SC, Nishi MY, Billerbeck AE, Libório DC, et al. SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability. Clin Endocrinol 2007;66:130–5.10.1111/j.1365-2265.2006.02698.xSuche in Google Scholar PubMed

12. Hirschfeldova K, Solc R, Baxova A, Zapletalova J, Kebrdlova V, et al. SHOX gene defects and selected dysmorphic signs in patients of idiopathic short stature and Léri-Weill dyschondrosteosis. Gene 2012;491:123–7.10.1016/j.gene.2011.10.011Suche in Google Scholar PubMed

13. Sandoval GT, Jaimes GC, Barrios MC, Cespedes C, Velasco HM. SHOX gene and conserved noncoding element deletions/duplications in Colombian patients with idiopathic short stature. Mol Genet Genomic Med 2014;2:95–102.10.1002/mgg3.39Suche in Google Scholar PubMed PubMed Central

14. Marstrand-Joergensen MR, Jensen RB, Aksglaede L, Duno M, Juul A. Prevalence of SHOX haploinsufficiency among short statured children. Pediatr Res 2017;81:335–41.10.1038/pr.2016.233Suche in Google Scholar PubMed

15. Delil K, Karabulut HG, Hacıhamdioğlu B, Şıklar Z, Berberoğlu M, et al. Investigation of SHOX gene mutations in Turkish patients with ıdiopathic short stature. J Clin Res Pediatr Endocrinol 2016;8:144–9.10.4274/jcrpe.2307Suche in Google Scholar PubMed PubMed Central

16. Binder G, Renz A, Martinez A, Keselman A, Hesse V, et al. SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity. J Clin Endocrinol Metab 2004;89:4403–8.10.1210/jc.2004-0591Suche in Google Scholar PubMed

17. Ross JL, Scott C Jr, Marttila P, Kowal K, Nass A, et al. Phenotypes associated with SHOX deficiency. J Clin Endocrinol Metab 2001;86:5674–80.10.1210/jcem.86.12.8125Suche in Google Scholar PubMed

18. Grigelioniene G, Schoumans J, Neumeyer L, Ivarsson A, Eklöf O, et al. Analysis of short stature homeobox-containing gene (SHOX) and auxological phenotype in dyschondrosteosis and isolated Madelung deformity. Hum Genet 2001;109:551–8.10.1007/s00439-001-0609-ySuche in Google Scholar PubMed

19. Schiller S, Spranger S, Schechinger B, Fukami M, Merker S, et al. Phenotypic variation and genetic heterogeneity in Léri-Weill syndrome. Eur J Hum Genet 2000;8:54–62.10.1038/sj.ejhg.5200402Suche in Google Scholar PubMed

20. Shears DJ, Vassal HJ, Goodman FR, Palmer RW, Reardon W, et al. Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat Genet 1998;19:70–3.10.1038/ng0198-70Suche in Google Scholar PubMed

21. Ellison JW, Wardak Z, Young MF, Gehron Robey P, Laig-Webster M, et al. PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Hum Mol Genet 1997;6:1341–7.10.1093/hmg/6.8.1341Suche in Google Scholar PubMed

22. Zinn AR, Wei F, Zhang L, Elder FF, Scott CI Jr, et al. Complete SHOX deficiency causes Langer mesomelic dysplasia. Am J Med Genet 2002;110:158–63.10.1002/ajmg.10422Suche in Google Scholar PubMed

23. Neyzi O, Bundak R, Gökçay G, Günöz H, Furman A, et al. Reference values for weight, height, head circumference, and body mass index in Turkish children. J Clin Res Pediatr Endocrinol 2015;7:280–93.10.4274/jcrpe.2183Suche in Google Scholar PubMed PubMed Central

24. Turan S, Bereket A, Omar A, Berber M, Ozen A, et al. Upper segment/lower segment ratio and armspan-height difference in healthy Turkish children. Acta Paediatr 2005;94:407–13.10.1111/j.1651-2227.2005.tb01909.xSuche in Google Scholar PubMed

25. Bundak R, Bas F, Furman A, Günöz H, Darendeliler F, et al. Sitting height and sitting height/height ratio references for Turkish children. Eur J Pediatr 2014;173:861–9.10.1007/s00431-013-2212-3Suche in Google Scholar PubMed

26. Elmlinger MW, Kühnel W, Weber MM, Ranke MB. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin Chem Lab Med 2004;42:654–64.10.1515/CCLM.2004.112Suche in Google Scholar PubMed

27. Gatta V, Antonucci I, Morizio E, Palka C, Fischetto R, et al. Identification and characterization of different SHOX gene deletions in patients with Leri-Weill dyschondrosteosys by MLPA assay. J Hum Genet 2007;52:21–7.10.1007/s10038-006-0074-5Suche in Google Scholar PubMed

28. Salmon-Musial AS, Rosilio M, David M, Huber C, Pichot E, et al. Clinical and radiological characteristics of 22 children with SHOX anomalies and familial short stature suggestive of Léri-Weill dyschondrosteosis. Horm Res Paediatr 2011;76: 178–85.10.1159/000329359Suche in Google Scholar PubMed

29. Munns CF, Glass IA, Flanagan S, Hayes M, Williams B, et al. Familial growth and skeletal features associated with SHOX haploinsufficiency. J Pediatr Endocrinol Metab 2003;16: 987–96.10.1515/JPEM.2003.16.7.987Suche in Google Scholar PubMed

30. Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, et al. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome. Horm Res 2009;71:167–72.10.1159/000197874Suche in Google Scholar PubMed

31. Blum WF, Crowe BJ, Quigley CA, Jung H, Cao D, et al. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metab 2007;92:219–28.10.1210/jc.2006-1409Suche in Google Scholar PubMed

32. Munns CF, Berry M, Vickers D, Rappold GA, Hyland VJ, et al. Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency. J Pediatr Endocrinol Metab 2003;16:997–1004.10.1515/JPEM.2003.16.7.997Suche in Google Scholar PubMed

33. Saenger P, Bondy CA. Turner syndrome. In: Sperling MA, editor. Pediatric endocrinology. 4th ed. Philadelphia, PA: Elsevier Saunders, 2014:664–96, chap 16.10.1016/B978-1-4557-4858-7.00025-1Suche in Google Scholar

Received: 2018-01-20
Accepted: 2018-09-25
Published Online: 2018-10-17
Published in Print: 2018-11-27

©2018 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Original Articles
  3. Carotid intima media thickness and associations with serum osteoprotegerin and s-RANKL in children and adolescents with type 1 diabetes mellitus with increased risk for endothelial dysfunction
  4. Cardiometabolic risk factors in preschool children with abdominal obesity from Medellín, Colombia
  5. Long-term follow-up of gonadal dysfunction in morbidly obese adolescent boys after bariatric surgery
  6. Prevalence of overweight and obesity and anthropometric reference centiles for Albanian children and adolescents living in four Balkan nation-states
  7. High urate concentration is associated with elevated blood pressure in schoolchildren
  8. The association of hs-CRP and fibrinogen with anthropometric and lipid parameters in non-obese adolescent girls with polycystic ovary syndrome
  9. Leptin and adiposity as mediators on the association between early puberty and several biomarkers in European adolescents: the HELENA Study
  10. Adolescents with premenstrual syndrome: not only what you eat but also how you eat matters!
  11. Thyroid dysfunction in children with leukemia over the first year after hematopoietic stem cell transplantation
  12. Morning vs. bedtime levothyroxine administration: what is the ideal choice for children?
  13. Basal characteristics and first year responses to human growth hormone (GH) vary according to diagnostic criteria in children with non-acquired GH deficiency (naGHD): observations from a single center over a period of five decades
  14. The prevalence and volumetry of pituitary cysts in children with growth hormone deficiency and idiopathic short stature
  15. SHOX gene deletion screening by FISH in children with short stature and Madelung deformity and their characteristics
  16. FGFR3-related hypochondroplasia: longitudinal growth in 57 children with the p.Asn540Lys mutation
  17. Case Reports
  18. A variable course of Cushing’s disease in a 7 year old: diagnostic dilemma
  19. Severe hyperchylomicronemia in two infants with novel APOC2 gene mutation
Heruntergeladen am 19.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2018-0038/pdf
Button zum nach oben scrollen